296 related articles for article (PubMed ID: 14613970)
1. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.
Karban AS; Okazaki T; Panhuysen CI; Gallegos T; Potter JJ; Bailey-Wilson JE; Silverberg MS; Duerr RH; Cho JH; Gregersen PK; Wu Y; Achkar JP; Dassopoulos T; Mezey E; Bayless TM; Nouvet FJ; Brant SR
Hum Mol Genet; 2004 Jan; 13(1):35-45. PubMed ID: 14613970
[TBL] [Abstract][Full Text] [Related]
2. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
[TBL] [Abstract][Full Text] [Related]
4. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
[TBL] [Abstract][Full Text] [Related]
5. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
[TBL] [Abstract][Full Text] [Related]
6. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
[TBL] [Abstract][Full Text] [Related]
7. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Riemann K; Becker L; Struwe H; Nückel H; Dührsen U; Alakus H; Winde G; Neuhäuser M; Rübben H; Schmitz KJ; Wohlschlaeger J; Schmid KW; Siffert W
Pharmacogenet Genomics; 2006 Nov; 16(11):783-8. PubMed ID: 17047486
[TBL] [Abstract][Full Text] [Related]
8. Screening of tumor necrosis factor receptor-associated factor 6 as a candidate gene for inflammatory bowel disease.
Lappalainen M; Paavola-Sakki P; Halme L; Turunen U; Heliö T; Färkkilä M; Kontula K
Scand J Gastroenterol; 2006 Apr; 41(4):424-9. PubMed ID: 16635910
[TBL] [Abstract][Full Text] [Related]
9. No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort.
Mirza MM; Fisher SA; Onnie C; Lewis CM; Mathew CG; Sanderson J; Forbes A
Gut; 2005 Aug; 54(8):1205-6. PubMed ID: 16009698
[No Abstract] [Full Text] [Related]
10. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
11. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
12. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
Haas SL; Andreas Koch W; Schreiber S; Reinhard I; Koyama N; Singer MV; Böcker U
Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892
[TBL] [Abstract][Full Text] [Related]
13. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
Dideberg V; Kristjansdottir G; Milani L; Libioulle C; Sigurdsson S; Louis E; Wiman AC; Vermeire S; Rutgeerts P; Belaiche J; Franchimont D; Van Gossum A; Bours V; Syvänen AC
Hum Mol Genet; 2007 Dec; 16(24):3008-16. PubMed ID: 17881657
[TBL] [Abstract][Full Text] [Related]
14. The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.
Héron E; Deloukas P; van Loon AP
Genomics; 1995 Dec; 30(3):493-505. PubMed ID: 8825636
[TBL] [Abstract][Full Text] [Related]
15. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population.
Oliver J; Gómez-García M; Paco L; López-Nevot MA; Piñero A; Correro F; Martín L; Brieva JA; Nieto A; Martín J
Inflamm Bowel Dis; 2005 Jun; 11(6):576-9. PubMed ID: 15905705
[TBL] [Abstract][Full Text] [Related]
16. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma.
Zhou B; Rao L; Li Y; Gao L; Wang Y; Chen Y; Xue H; Song Y; Peng Y; Liao M; Zhang L
Cancer Lett; 2009 Mar; 275(1):72-6. PubMed ID: 19006646
[TBL] [Abstract][Full Text] [Related]
17. A polymorphism in the IL11 gene is associated with ulcerative colitis.
Klein W; Tromm A; Griga T; Fricke H; Folwaczny C; Hocke M; Eitner K; Marx M; Duerig N; Epplen JT
Genes Immun; 2002 Dec; 3(8):494-6. PubMed ID: 12486609
[TBL] [Abstract][Full Text] [Related]
18. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
20. NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors.
Burnik FS; Yalçin S
Chemotherapy; 2009; 55(5):381-5. PubMed ID: 19752553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]